Cord Blood Bank Sponsors Free Mother's Day Giveaway and Infant CPR Training
Cord Blood Bank Gives Back to Community with Mother's Day Giveway and Free Infant CPR Training
Early Study Results Show New Stem Cell Treatment Successfully Treats Critical Limb Ischemia (CLI) Patients: First results of randomized, placebo-c
Harvest Technologies Corp. (www.harvesttech.com) announced today that Claas Ludermann, MD, a specialist in vascular medicine, presented preliminary data at the 74th Annual Meeting of the German Society of Cardiology from a clinical trial being conducted at the Berlin (Germany) Vascular Center of Franziskus Hospital under the direction of Berthold Amman, MD. The "BONe Marrow Outcome Trial-2" (BONMOT-2) is a randomized, controlled, double-blinded study treating patients with end-stage peripheral vascular disease (Critical Limb Ischemia, or CLI), using a cellular composition of autologous stem cells. This same treatment methodology has shown to be very ...
BioCardia and the University of Miami Receive FDA Clearance to Initiate Co-Sponsored Heart Failure Stem Cell Clinical Trial Comparing Two Cell Populat
BioCardia, Inc., a regenerative medicine company, and the University of Miami today announced that the United States Food and Drug Administration approved a clinical investigation of two adult stem cell populations in the setting of heart failure.
Regenerative Medicine Cases Using Adult Stem Cells Are Available at www.AutologousAdultStemCells.org
Ronald Trahan Associates ("RTA") Inc. announced today the availability of several podcasts at www.AutologousAdultStemCells.org that show how clinicians and researchers from around the world are using autologous adult stem cells to treat cardiovascular, orthopedic and vascular indications at a patient's point-of-care.
ImmuneRegen Releases Results from UMDNJ Study Confirming Homspera's Adult Stem Cell Activity: Tests on Human Bone Marrow by World Leader in Stem C
ImmuneRegen(R) BioSciences, Inc., a wholly owned biotechnology product development and licensing subsidiary of IR BioSciences Holdings, Inc. (OTCBB:IRBO), today announced the results of a bone marrow study involving Homspera. Results point to the ability of Homspera to enhance formation of early-stage blood cells from adult hematopoietic (blood-forming) stem cells. The studies, performed by University of Medicine and Dentistry of New Jersey (UMDNJ) Professor Pranela Rameshwar, Ph.D, not only were consistent with previous stem cell study results, but also demonstrated the potency of Homspera.
Americans for Cures Foundation Announces 'Big Give' Star to Speak at Stem Cell Advocacy Conference
Americans for Cures Foundation is proud to announce that Carlana Stone, a star of Oprah Winfrey's "Big Give," will be speaking at its first State of Stem Cell Advocacy (SOSCA) Conference on April 12-13 at the UCSF Mission Bay Conference Center in San Francisco.
BioTime, Inc. Signs Letter of Intent With International Stem Cell Corporation for Joint Production and Distribution of Stem Cell Products
BioTime, Inc. (OTCBB:BTIM) and its wholly-owned subsidiary Embryome Sciences, Inc., have signed a letter of intent with International Stem Cell Corporation (OTCBB:ISCO) and its wholly-owned subsidiary Lifeline Cell Technology (Lifeline) to jointly produce and distribute a wide array of research products from human embryonic stem cell technology.
Amorcyte Completes Phase I Trial of Stem Cell Therapy for Acute Myocardial Infarction
Amorcyte, Inc. (Amorcyte) announced today the completion of the phase I clinical trial of its lead product, AMR-001 - an autologous stem cell product for the treatment of damaged heart muscle following acute myocardial infarction (AMI).
Waterfront Media, Publisher of WhatToExpect.com, and Cord Blood Registry, World's Most Experienced Cord Blood Bank, Announce Partnership to Better Ed
Waterfront Media, the publisher of WhatToExpect.com, the online website based on the bestselling series of What to Expect pregnancy and parenting books, and Cord Blood Registry (CBR), the global leader in cord blood banking, announce the launch of Considering Cord Blood Banking. The new section at WhatToExpect.com is the focus of a partnership between Waterfront Media and CBR to empower expectant parents with better information about the medical benefits of cord blood stem cells and the options for either preserving them for a family's own use in the future, or donating them for others in need.
Best in Nation State Spyware Law Updated; Consumers Get Protection in Seeking Stem Cord Blood Storage in Morris bill Signed Into Law
During today's bill-signing ceremony at the Capital, Governor Christine Gregoire approved an update to the landmark spyware law in SHB 2879 . Washington's spyware law has been called the best in the nation being the only State law used in court to stop spyware on consumer home computers. House Bill 2431 will inform expecting parents of their option to store away the cord blood immediately following the birth of their child. Contact: Jeff Morris 360-946-5678
Downloadable photo: http://www1.leg.wa.gov/documents/house/members/photos/morris.jpg. Radio and TV News Directors: To obtain broadcast-quality audio on thes...
Family Cord Blood Services Provides Free Infant CPR Training
Cord Blood Bank Provides Free Infant CPR Training and Certification to Expectant Parents
Harvest Technologies Announces Patient Enrollment Has Begun for a Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients with Non
Harvest Technologies Corp. (www.harvesttech.com) announced today that a 60-patient clinical trial using the Company's BMAC(TM) System to treat patients with non-reconstructible Critical Limb Ischemia (CLI) is now underway at Shri Ramachandra Medical Center, a Harvard Medical international-associated institution based in Chennai, India, one of the largest private healthcare facilities in South Asia. The study is being led by principal investigator Prof. K. S. Vijayaragavan, Head of Vascular Surgery at Sri Ramachandra University. Harvest's BMAC System is a point-of-care device for concentrating a patient's own (autologous) bone marrow stem cells in app...
Harvest Technologies to Present at '3rd Annual Stem Cell Summit': President Gary Tureski to review the scientific foundation leading
to first rand
Harvest Technologies Corp. (www.harvesttech.com) announced today its President, Gary Tureski, will present at the Third Annual Stem Cell Summit, Hilton New York, on Tuesday, Feb. 26, 2008. The annual Stem Cell Summit brings together the leading industry, investment, practitioner, and research innovators within the rapidly expanding field of stem cells.
Dr. Charles A. Sims of California Cryobank's Family Cord Blood Services Apppointed to National Stem Cell Advisory Council
Sims to Represent Association of Family Cord Blood Banks
S Korean Stem Cell Firm Enters Into an Agreement with Tiantan Puhua Hospital in China
RNL Bio entered into an agreement with Tiantan Puhua Hospital for stem cell treatments for complications including spinal cord injury, hair loss and osteoarthritis.